A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
← catalyst calendarNCT07245407 · readout in 344 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
320estimated
Sites
38
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-10-27 | actual | When the study began enrolling |
| Primary completion | 2027-07-29 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-07-29 | estimated | The whole study's end, after follow-up |
| First posted | 2025-11-24 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Non-cystic Fibrosis Bronchiectasis
Intervention
- Other: Participant Follow-up
Primary outcomes
what the primary-completion date above is the date OFFEV1/FVC%
measured 12 month
FEF25-75 L/s
measured 12 month
FENO ppb
measured 12 month
HRCT
measured 12 month
cell percentage (%)
measured 12 month
Gene expression read counts by RNAseq
measured 12 month
Molecular deliverables
measured 12 month
on-set age(years-old)
measured 12 month
Sex(M/F)
measured 12 month
body mass index(kg/m^2)
measured 12 month
comorbidities
measured 12 month
medical history
measured 12 month
smoking status(never/current/former)
measured 12 month
smoking pack years(pack/year)
measured 12 month
Sputum microbiology (CFU)
measured 12 month
Historical Exacerbation
measured 12 month
BSI score
measured 12 month
QoL-B-RSS
measured 12 month
BHQ
measured 12 month
BEST
measured 12 month
Treatment pattern
measured 12 month
Exacerbation assessment
measured 12 month
Cell counts (10^9/L)
measured 12 month
Exacerbation assessment about hospitalization
measured 12 month
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed